CSF3 and neutropenia: For this subgroup of patients, both granulocyte colony‐stimulating factor (GCSF) and 1‐palmitoyl‐2‐linoleoyl‐3‐acetyl‐rac‐glycerol (PLAG), a synthetic monoacetyldiglyceride, have shown potential clinical effectiveness in reducing GEM‐induced neutropenia.26